A biotech startup leads a new effort to edit human embryos therapeutically, hoping technical advances will persuade ...

A multi-omics study has mapped stage-specific lipid remodeling across human stem cell differentiation into cardiomyocytes, ...

For years, the dream of correcting disease-causing DNA in human embryos has been shadowed by a hard biological reality: the ...

For decades, the idea of growing human tissue inside another species sounded like something that belonged in a science fiction movie. Today, laboratories are exploring a far more practical version of ...

Colossal Biosciences CEO Ben Lamm says bringing extinct species back can contribute to conservation, healthcare and ...

University of Sydney researchers have developed a new way to test how closely lab-grown biological models resemble real human ...

For decades, scientists have dreamed of peering into the earliest days of human life, those fragile moments when a fertilized ...

The practice of editing the genes of embryos remains highly controversial and risky, but Origin Genomics founder Cathy Tie argues its a “moral imperative” to address hereditary diseases. When the ...

Origin Genomics aims to prove the potential benefits of its technology for editing disease-causing genes in human embryos ...

University of Sydney researchers have developed a powerful way to test how closely lab-grown biological models resemble real human embryos, finding that while some models perform well, none yet fully ...

The first humans are trying out cellular reprogramming for longevity. It looks like it might be working.